New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health ...

Adults with plaque psoriasis aged 65 years and older had similar responses to IL-17 and IL-23 inhibitors to that of younger adults.

While actives like vitamin C, kojic acid, niacinamide, and alpha arbutin do work, they’re a double-edged sword.

How the earth’s rotation taught me to find peace in the face of death.

A retrospective analysis of US medical records of people aged 65-95 years finds those with psoriasis on systemic therapies ...

Both mild and moderate-to-severe psoriasis are significantly associated with an increased risk for sleep disorders, according ...

Bimekizumab use for 4 years among patients with plaque psoriasis is associated with sustained efficacy outcomes and no new safety signals.

Discover a study in which researchers examined three international cohorts of patients with moderate-to-severe psoriasis ...

For patients with psoriasis receiving biologic therapy, residual inflammation (RI), defined as increased inflammatory markers in blood, characterized by high-sensitivity C-reactive protein, despite ...

8% of patients maintained that the ongoing war had affected the quality of the treatment they are receiving for psoriasis.

If you have psoriasis, you may feel like this autoimmune ... a dermatologic surgeon, and a healthy skin advocate. Her practice philosophy focuses on patient education, with a holistic approach ...

Discover how simple lifestyle changes — like exercise, diet, and better sleep — can help reduce symptoms and improve quality ...